Progression-Free Survival Increased Fivefold, Intracranial Response Rate at 65.7%! ‘Miraculous Anti-Cancer Drug’ Solves the Treatment Challenge of Breast Cancer Brain Metastases

Progression-Free Survival Increased Fivefold, Intracranial Response Rate at 65.7%! 'Miraculous Anti-Cancer Drug' Solves the Treatment Challenge of Breast Cancer Brain Metastases

What else can DS-8201 not do? Recently, the “miraculous anti-cancer drug” DS-8201 announced data from its DESTINY-Breast03 trial involving patients with brain metastases[1]: Among 43 patients with HER2-positive breast cancer brain metastases treated with DS-8201, the median progression-free survival reached 15.0 months, with intracranial objective response rate and overall objective response rate at 65.7% and … Read more

Clinical Research Confirms DS-8201 Effectively Treats Brain Metastases from Breast Cancer

Clinical Research Confirms DS-8201 Effectively Treats Brain Metastases from Breast Cancer

Written by Wang Cong Edited by Wang Duoyu Formatted by Shui Chengwen Breast cancer has the highest incidence rate among malignant tumors in women, thus it is referred to as the “pink killer.” According to the global cancer burden data released by the International Agency for Research on Cancer (IARC) in 2020, breast cancer has … Read more